Verano Holdings Corp. (VRNOF)
(Delayed Data from OTC)
$3.62 USD
-0.28 (-7.18%)
Updated Aug 2, 2024 03:59 PM ET
4-Sell of 5 4
B Value B Growth B Momentum A VGM
Brokerage Reports
Verano Holdings Corp. [VRNOF]
Reports for Purchase
Showing records 41 - 60 ( 145 total )
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Ohio State Primer, Likely Positive Ballot Vote November 7th
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: MSO Benchmark Scoring Ahead of 3Q23 Earnings
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis Industry 3Q23 Insight
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Strong Fundamentals, Attractive Valuation, and US Regulatory Catalysts Provides Risk/Reward Optimization. Reiterate Top Pick.
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis Remains a State Led Growth Story
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Equitization of Debt to Rebalance Balance Seets
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Valuation Expectations Framework
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Cannabis Returns Sustainable on LT Catalyst Unlocks
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Monumental ReScheduling Signals U.S. Cannabis Normalization
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: An Update on Cannabis Capital Raising
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Solid Q223 Beckons a Stronger H223, Raised FCF Guidance a Positive Sign of Stabilizing Industry Outlook
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
2Q23 Solid Execution Lifts Cash Flow Generation, Reit Buy
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: 2Q23 U.S. Cannabis Industry Earnings Preview
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Rescheduling Process Recommendation Expected By Year End
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Cannabis Industry Update: June 2023 Performance and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Quality at a Discount: Attractive FCF Yield, Solid Balance Sheet
Provider: Echelon Welath Partners
Analyst: SEMPLE A